Will Melco Crown Entertainment (MPEL) Stock be Affected by Macau Revenue Results?

NEW YORK (TheStreet) -- Shares of Melco Crown Entertainment (MPEL), a casino operator in Asia, closed higher by 0.17% to $20.79 on Monday. This afternoon the Macau gaming hub in China released its April 2015 revenue results, and posted a 38.8% year-over-year decline, the eleventh consecutive month of falling revenue, Reuters reports.

High stakes and VIP players have been avoiding the Macau gambling sector ever since China leader Xi Jinping began cracking down on corruption in Macau.

The cleanup in Macau is focusing on illicit outflow of money from China, Reuters said, adding that since the anti-corruption practices began revenue in the gaming region has slumped.

Macau revenue in April 2015 slipped to 19.167 billion patacas ($2.40 billion) from 31.318 billion patacas when compared to the prior year.

Analysts were expecting a decline between 38% and 40% in April, Reuters said.

Separately, TheStreet Ratings team rates MELCO CROWN ENTMT LTD as a Buy with a ratings score of B-. TheStreet Ratings Team has this to say about their recommendation:

"We rate MELCO CROWN ENTMT LTD (MPEL) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had somewhat weak growth in earnings per share."

Highlights from the analysis by TheStreet Ratings Team goes as follows:

  • The debt-to-equity ratio is somewhat low, currently at 0.98, and is less than that of the industry average, implying that there has been a relatively successful effort in the management of debt levels. Along with this, the company maintains a quick ratio of 2.59, which clearly demonstrates the ability to cover short-term cash needs.
  • MPEL, with its decline in revenue, underperformed when compared the industry average of 7.0%. Since the same quarter one year prior, revenues fell by 19.6%. Weakness in the company's revenue seems to have hurt the bottom line, decreasing earnings per share.
  • Despite any intermediate fluctuations, we have only bad news to report on this stock's performance over the last year: it has tumbled by 40.23%, worse than the S&P 500's performance. Consistent with the plunge in the stock price, the company's earnings per share are down 57.50% compared to the year-earlier quarter. Looking ahead, the stock's sharp decline over the past year may have been what was needed in order to bring its value into alignment with its fundamentals and others in its industry.
  • MELCO CROWN ENTMT LTD has experienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. Earnings per share have declined over the last year. We anticipate that this should continue in the coming year. During the past fiscal year, MELCO CROWN ENTMT LTD reported lower earnings of $1.10 versus $1.15 in the prior year. For the next year, the market is expecting a contraction of 34.1% in earnings ($0.73 versus $1.10).
  • You can view the full analysis from the report here: MPEL Ratings Report

More from Markets

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

REPLAY: Jim Cramer on How to Navigate the Stock Market Amid Tariff Worries

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

Global Markets Hit Hard; AMC Entertainment Sells Stake in Ad Unit -- ICYMI

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

CVS, Walgreens and Citigroup: Cramer's 'Off the Charts'

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

Jim Cramer: 4 Stocks Could Get Throttled By a 'Knock Down Drag Out' With China

General Electric Booted From Dow, Replaced by Walgreens

General Electric Booted From Dow, Replaced by Walgreens